Intractable Generalized Epilepsy: Therapeutic Approaches

[1]  A. Rotenberg,et al.  Dietary, immunological, surgical, and other emerging treatments for pediatric refractory status epilepticus , 2019, Seizure.

[2]  D. Coyle,et al.  Cannabis‐based products for pediatric epilepsy: A systematic review , 2018, Epilepsia.

[3]  A. Saghazadeh,et al.  Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescents with epilepsy: A systematic review and meta-analysis , 2017, Nutritional neuroscience.

[4]  Sean T. Hwang,et al.  Validation of corpus callosotomy after laser interstitial thermal therapy: a multimodal approach. , 2019, Journal of neurosurgery.

[5]  P. Gorelick,et al.  The Feasibility, Safety and Effectiveness of a Ketogenic Diet for Refractory Status Epilepticus in Adults in the Intensive Care Unit , 2018, Neurocritical Care.

[6]  James W. Wheless,et al.  Vagus nerve stimulation (VNS) therapy update , 2018, Epilepsy & Behavior.

[7]  S. Gulati.  Dietary Therapies: Emerging Paradigms in Therapy of Drug Resistant Epilepsy in Children , 2018, The Indian Journal of Pediatrics.

[8]  Dong Seok Kim,et al.  Long-term Outcome of Resective Epilepsy Surgery in Patients With Lennox-Gastaut Syndrome , 2018, Pediatrics.

[9]  R. Keating,et al.  Early outcomes of stereoelectroencephalography followed by MR-guided laser interstitial thermal therapy: a paradigm for minimally invasive epilepsy surgery. , 2018, Neurosurgical focus.

[10]  Zulma Tovar-Spinoza,et al.  Single and staged laser interstitial thermal therapy ablation for cortical tubers causing refractory epilepsy in pediatric patients. , 2018, Neurosurgical focus.

[11]  O. Dulac,et al.  Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood? , 2018, Epilepsia.

[12]  J. García-Peñas,et al.  Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12‐month GENERAL study , 2018, Epilepsia.

[13]  I. Scheffer,et al.  Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group , 2018, Epilepsia open.

[14]  E. Wirrell,et al.  Ketogenic Diet Therapy in Infants: Efficacy and Tolerability. , 2018, Pediatric neurology.

[15]  Y. Sogawa,et al.  Use of Vagus Nerve Stimulator on Children With Primary Generalized Epilepsy , 2018, Journal of child neurology.

[16]  Eric Marsh,et al.  Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial , 2018, The Lancet.

[17]  T. Loddenkemper,et al.  New‐onset refractory status epilepticus (NORSE) and febrile infection–related epilepsy syndrome (FIRES): State of the art and perspectives , 2018, Epilepsia.

[18]  Ingrid E. Scheffer,et al.  The new definition and classification of seizures and epilepsy , 2018, Epilepsy Research.

[19]  Jingwei Xu,et al.  The Anticonvulsant Effects of Ketogenic Diet on Epileptic Seizures and Potential Mechanisms , 2017, Current neuropharmacology.

[20]  R. Foroozan.  Vigabatrin: Lessons Learned From the United States Experience , 2017, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[21]  A. Asadi-Pooya.  Lennox-Gastaut syndrome: a comprehensive review , 2018, Neurological Sciences.

[22]  C. Press,et al.  Ketogenic Diet in Super-Refractory Status Epilepticus , 2017, Pediatric Neurology Briefs.

[23]  M. Elia,et al.  Ketogenic Diets in the Treatment of Epilepsy. , 2017, Current pharmaceutical design.

[24]  H. Steiger,et al.  Efficacy of adjunctive vagus nerve stimulation in patients with Dravet syndrome: A meta-analysis of 68 patients , 2017, Seizure.

[25]  D. Mu,et al.  Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies , 2017, World Journal of Pediatrics.

[26]  I. Scheffer,et al.  Trial of Cannabidiol for Drug‐Resistant Seizures in the Dravet Syndrome , 2017, The New England journal of medicine.

[27]  A. Verrotti,et al.  Anticonvulsant drugs for generalized tonic-clonic epilepsy , 2017, Expert opinion on pharmacotherapy.

[28]  A. Ostendorf,et al.  Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions , 2017, Neuropsychiatric disease and treatment.

[29]  T. Bast,et al.  Modified Atkins diet is an effective treatment for children with Doose syndrome , 2017, Epilepsia.

[30]  P. Camfield,et al.  Outcome of childhood-onset epilepsy from adolescence to adulthood: Transition issues , 2017, Epilepsy & Behavior.

[31]  H. Chugani,et al.  Corpus Callosotomy for Intractable Epilepsy Revisited: The Children’s Hospital of Michigan Series , 2017, Journal of child neurology.

[32]  R. Leroy,et al.  Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension , 2017, Epilepsy Research.

[33]  S. Mirsattari,et al.  Prognostic factors in patients with refractory idiopathic generalized epilepsy , 2017, Epilepsy Research.

[34]  E. Yacubian.  Juvenile myoclonic epilepsy: Challenges on its 60th anniversary , 2017, Seizure.

[35]  J. Rho.  How does the ketogenic diet induce anti-seizure effects? , 2017, Neuroscience Letters.

[36]  A. Palmini,et al.  Selective posterior callosotomy for drop attacks , 2016, Neurology.

[37]  Suvasini Sharma,et al.  Evaluation of a simplified modified Atkins diet for use by parents with low levels of literacy in children with refractory epilepsy: A randomized controlled trial , 2016, Epilepsy Research.

[38]  J. French,et al.  Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study , 2016, The Lancet.

[39]  D. Rose,et al.  Resection of ictal high frequency oscillations is associated with favorable surgical outcome in pediatric drug resistant epilepsy secondary to tuberous sclerosis complex , 2016, Epilepsy Research.

[40]  F. Khan,et al.  Valproic Acid versus Lamotrigine as First-line Monotherapy in Newly Diagnosed Idiopathic Generalized Tonic -Clonic Seizures in Adults - A Randomized Controlled Trial. , 2016, Journal of clinical and diagnostic research : JCDR.

[41]  D. Gill,et al.  Corpus callosotomy outcomes in pediatric patients: A systematic review , 2016, Epilepsia.

[42]  Steve S. Chung,et al.  Clobazam and clonazepam use in epilepsy: Results from a UK database incident user cohort study , 2016, Epilepsy Research.

[43]  A. Marson,et al.  Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review. , 2016, The Cochrane database of systematic reviews.

[44]  K. Engelstad,et al.  Diagnosing Glucose Transporter 1 Deficiency at Initial Presentation Facilitates Early Treatment. , 2016, The Journal of pediatrics.

[45]  H. Yoshinaga,et al.  Long-term safety and seizure outcome in Japanese patients with Lennox–Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial , 2016, Epilepsy Research.

[46]  I. Helbig,et al.  Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy , 2016, Genetics in Medicine.

[47]  Hoon-Chul Kang,et al.  Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy , 2016, Epilepsia.

[48]  Edward F. Chang,et al.  Rates and Predictors of Seizure Freedom With Vagus Nerve Stimulation for Intractable Epilepsy , 2015, Neurosurgery.

[49]  P. Iversen,et al.  A prospective study of the modified Atkins diet for adults with idiopathic generalized epilepsy , 2015, Epilepsy & Behavior.

[50]  J. Téllez-Zenteno,et al.  Predicting drug resistance in adult patients with generalized epilepsy: A case–control study , 2015, Epilepsy & Behavior.

[51]  J. González-Martínez,et al.  Resective Epilepsy Surgery for Tuberous Sclerosis in Children: Determining Predictors of Seizure Outcomes in a Multicenter Retrospective Cohort Study. , 2015, Neurosurgery.

[52]  Dario J. Englot,et al.  Corpus callosotomy versus vagus nerve stimulation for atonic seizures and drop attacks: A systematic review , 2015, Epilepsy & Behavior.

[53]  G. Krauss,et al.  Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy , 2015, Neurology.

[54]  P. Camfield,et al.  Incidence, prevalence and aetiology of seizures and epilepsy in children. , 2015, Epileptic disorders : international epilepsy journal with videotape.

[55]  Steve S. Chung,et al.  Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy , 2015, Neurology.

[56]  Xiaojia Li,et al.  Efficacy of and Patient Compliance with a Ketogenic Diet in Adults with Intractable Epilepsy: A Meta-Analysis , 2015, Journal of clinical neurology.

[57]  E. Beghi,et al.  Epidemiologic aspects: Lost in transition , 2014, Epilepsia.

[58]  M. Sperling,et al.  Ketogenic diet in adolescents and adults with epilepsy , 2014, Seizure.

[59]  J. Paolicchi,et al.  Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years , 2014, Epilepsia.

[60]  P. Kwan,et al.  Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double‐blind, randomized, placebo‐controlled, flexible‐dose trial , 2014, Epilepsia.

[61]  Bertil Rydenhag,et al.  Long-term follow-up after callosotomy—A prospective, population based, observational study , 2013, Epilepsia.

[62]  Brahim Tabarki,et al.  Antiepileptic drugs , 2014, Reactions Weekly.

[63]  M. Smyth,et al.  Outcomes after anterior or complete corpus callosotomy in children. , 2014, Neurosurgery.

[64]  Antonio Valentín,et al.  Deep brain stimulation of the centromedian thalamic nucleus for the treatment of generalized and frontal epilepsies , 2013, Epilepsia.

[65]  T. Pieper,et al.  Towards early diagnosis and treatment to save children from catastrophic epilepsy – Focus on epilepsy surgery , 2013, Brain and Development.

[66]  J. Wheless,et al.  Clobazam: a newly approved but well-established drug for the treatment of intractable epilepsy syndromes. , 2013, Journal of child neurology.

[67]  N. Delanty,et al.  Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: Open‐label, noncomparative, multicenter, long‐term follow‐up study , 2012, Epilepsia.

[68]  M. Backer,et al.  A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs , 2010, CNS drugs.

[69]  E. Somerville.  Some treatments cause seizure aggravation in idiopathic epilepsies (especially absence epilepsy) , 2009, Epilepsia.

[70]  J. Cross,et al.  A randomized trial of classical and medium‐chain triglyceride ketogenic diets in the treatment of childhood epilepsy , 2009, Epilepsia.

[71]  L. James Willmore,et al.  Vigabatrin: 2008 Update , 2009, Epilepsia.

[72]  E Wyllie,et al.  Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings , 2007, Neurology.

[73]  P. Camfield,et al.  Long‐term Prognosis for Symptomatic (Secondarily) Generalized Epilepsies: A Population‐based Study , 2007, Epilepsia.

[74]  Jing Shen,et al.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial , 2007, The Lancet.

[75]  S. Shinnar,et al.  Felbamate: Consensus of current clinical experience , 2006, Epilepsy Research.

[76]  G. Bergey.  Evidence‐based Treatment of Idiopathic Generalized Epilepsies with New Antiepileptic Drugs , 2005, Epilepsia.

[77]  I. Valencia,et al.  Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. , 2004, Epileptic disorders : international epilepsy journal with videotape.

[78]  O. Dulac,et al.  Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial , 2000, The Lancet.

[79]  G. Pledger,et al.  A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures , 1999, Neurology.

[80]  G. Pledger,et al.  A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. , 1999, Neurology.

[81]  J M Freeman,et al.  A multicenter study of the efficacy of the ketogenic diet. , 1998, Archives of neurology.